SRF Q4 FY26 earnings call: Revenue & Margins
Q4 FY26 earnings call: what management said on revenue, margins and capex.
- Revenue
- ₹4,615Cr
- +7% YoY
- +24.3% QoQ
- Net profit
- ₹582Cr
- +10.6% YoY
- +34.4% QoQ
- Margin
- 22%
- 0 pp YoY
- +1 pp QoQ
Guidance rank: #50 of 70 in Chemicals & Petrochemicals
See the sector's top 10 — free with your mobile number.
The short version
Chemicals business expected to grow 15% to 20% in FY27 despite pricing pressures and volatility. Chemicals business expected to grow 15%-20% in FY27 driven by strong product pipeline, technological interventions, and ramp-up of fluoropolymers and HFO capacities.
From SRF Ltd's Q4 FY26 earnings-call transcript · updated 23 Sept 2026.
Revenue & Sales Performance
- Chemicals business expected to grow 15% to 20% in FY27 despite pricing pressures and volatility.
- Strong product pipeline critical, spanning from intermediates through to AI and specialty chemicals.
- Fluoropolymer segment ramp-up anticipated in latter half of current year, with good revenue ramp expected in FY27.
- Chemours arrangement starting post-December FY26 (Q4), expected to yield high-margin outcomes.
- Exports of aluminum foil have commenced, with further growth expected through 2027.
- Incremental capacity enhancements underway at HFC segment, targeting over 65,000 MT per annum post-debottlenecking.
- New HFO portfolio capacity of 20,000 MT planned at Odisha site, with commissioning expected by February 2028.
2 more points from SRF Ltd's call on revenue
Create a free account to keep reading this call
Profitability & Margins
See what SRF Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- INR2,300 crore investment at Odisha over next 2 years for fourth-generation refrigerant gases capacity (20,000 MT/year) plus backward integration into hydrofluoric acid (30,000 MT), including electronic grade HF.
- Planned capex of approximately INR2,500 crore for FY27 aligned with long-term growth priorities.
- Successful start-up of capacitor-grade BOPP films plant (KAPLAR); to be capitalized shortly.
- BOPP & BOPE line expected to commence production in July FY27.
- Investment of INR180 crore in state-of-the-art BOPA (polyamide) line, expected operational by September 2027 (India’s first with simultaneous stretching).
- Pharma intermediates plant number 2 is coming up; on track at Dahej.
- Ongoing debottlenecking in chemicals to increase capacity north of 65,000 MT/year.
2 more points from SRF Ltd's call on capex
Create a free account to keep reading this call
Top-ranked in Chemicals & Petrochemicals
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what SRF Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
- It was mentioned that the company has very strong demand pull currently, meaning robust order inflows.
- There is ongoing fulfillment of demand, including exports, with no significant inventory stocking noted.
- The fluoropolymer segment and aluminum exports are ramping up, with good customer interest and approvals in progress.
- Upcoming projects, like the Chemours arrangement, are expected to contribute positively to order execution from Q4 FY26 and into FY27.
2 more points from SRF Ltd's call on order book
Create a free account to keep reading this call
SRF Ltd — Quarterly revenue & net profit
SRF Ltd Q4 FY26 results — key figures
| ₹ Cr | Q4 FY26 | Q4 FY25 | YoY | Q3 FY26 | QoQ |
|---|---|---|---|---|---|
| Revenue | 4,615 | 4,313 | +7% | 3,713 | +24.3% |
| Operating profit (EBITDA) | 1,026 | 957 | +7.2% | 780 | +31.5% |
| Operating margin | 22% | 22% | 0 pp | 21% | +1 pp |
| Profit before tax | 757 | 707 | +7.1% | 452 | +67.5% |
| Net profit (PAT) | 582 | 526 | +10.6% | 433 | +34.4% |
| EPS (₹) | 19.63 | 17.75 | +10.6% | 14.60 | +34.5% |
Source: reported quarterly figures (Screener), ₹ crore.
Reported quarterly figures (₹ Cr). Latest (Q2 FY27): revenue ₹4.9K Cr, net profit ₹509 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What SRF's management said in earlier quarters
Others in Chemicals & Petrochemicals this season
- Indian Phosphate (Q4 FY26)
H2 FY26 Revenue (Consolidated):** ₹580.25 Cr, up from ₹451.59 Cr in H2 FY25 — a year-on-year increase of ₹128.66 Cr. Key investor presentation takeaways from In
- Paragon Fine (Q4 FY26)
Revenue for H2FY26:** Rs 68.88 Cr, up 7.41% YoY from Rs 64.13 Cr in H2FY25 (Page 22). Key investor presentation takeaways from Paragon Fine's Q4 FY26 investor p
- IVP (Q4 FY26)
Q4 FY26 revenue from operations: ₹164.44 crore . Key investor presentation takeaways from IVP's Q4 FY26 investor presentation — and how it ranks against sector
- Vishnu Chemicals (Q4 FY26)
Q4 FY26 Operating Revenues: ₹450.3 crore, up 14.7% YoY from ₹392.6 crore in Q4 FY25 (Page 5). Key investor presentation takeaways from Vishnu Chemicals Ltd's Q4
Potential multibaggers · Q2 FY27
Potential multibaggers in Chemicals & Petrochemicals
on management's own guidance
- Strong growth2
- Strong growth1
- Strong growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Arthneeti Pro · Annual
SRF Ltd and 15K+ more earnings calls,
for less than your morning chai
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were SRF Ltd Q4 FY26 results?
Chemicals business expected to grow 15% to 20% in FY27 despite pricing pressures and volatility. Chemicals business expected to grow 15%-20% in FY27 driven by strong product pipeline, technological interventions, and ramp-up of fluoropolymers and HFO capacities.
What is SRF Ltd share price analysis?
SRF Ltd currently shows a neutral. The stock trades at a P/E of 33.2 with a market cap of ₹74,462 Cr. Investors should review the full earnings analysis for detailed insights.
Is SRF Ltd planning capital expenditure?
INR2,300 crore investment at Odisha over next 2 years for fourth-generation refrigerant gases capacity (20,000 MT/year) plus backward integration into hydrofluoric acid (30,000 MT), including electronic grade HF.
Keep SRF Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.
